Dysregulated expression of the tumor suppressor p14ARF in cancer provides an effective target for TCR-T cell therapeuticsThomas M Schmitt(Fred Hutch Cancer Center), Aude G. Chapuis(University of Washington)Journal for ImmunoTherapy of CancerFebruary 1, 202610.1136/jitc-2025-013520Cited by 0SaveCiteExport RISWatch citationsRelated PapersAcquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA|Nature Communications|2018|284HA-1–targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation|Blood|2024|29